PBPH Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 -0.36%, SMA50 2.52%, SMA200 3.21%). The stock’s 14-day RSI is 51.55 (neutral), while the ATR of 0.31 points to moderate volatility. The stock remains sitting in the mid-range of its 52-week band, trading -2.83% below its high and over 10.38% above its low. Average 10-day trading volume of 88.95 thousand shares is below the 3-month average of 140.35 thousand, indicating normal recent market interest.

Portfolio Building Block World Pharma and Biotech Index ETF last paid a dividend of 0.02 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.

Portfolio Building Block World Pharma and Biotech Index ETF (NASDAQ:PBPH) closed at $27.80 USD, losing -$0.04 (-0.15%) from the previous close of $27.85. The stock is currently mid-range between its 52-week high and low $24.18 and $29.90. With a market capitalization of about $12.17 million, Portfolio Building Block World Pharma and Biotech Index ETF is classified as a micro-cap and shows lower-than-market volatility (beta ~0.05). Key stats such as the average daily volume over the past year has been around 141.78 thousand shares, in line with its 52-week average. Headquartered in Milwaukee, WI, Portfolio Building Block World Pharma and Biotech Index ETF operates in the Financial Services sector and the Asset Management industry. The Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is designed to give investors specific exposure to the worldwide pharmaceutical and biotechnology sectors.

Our AI price prediction model suggests that Portfolio Building Block World Pharma and Biotech Index ETF stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

currently trading near 52-week highs band.